Business Context and Reporting Period
Company: Weis Markets, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 27, 2009
Business Overview: A top 50 U.S. food and drug retailer operating 154 retail food stores across Pennsylvania, Maryland, New Jersey, West Virginia, and New York, plus 25 Superpetz pet supply stores. The company operates as a single reportable segment.
Key Financial Metrics
| Metric | 13 Weeks Ended June 27, 2009 |
26 Weeks Ended June 27, 2009 |
26 Weeks Ended June 28, 2008 |
|---|---|---|---|
| Net Sales | $615.4 million | $1,221.6 million | $1,199.1 million |
| Gross Profit | $166.0 million | $329.6 million | $310.8 million |
| Gross Margin | 27.0% | 27.0% | 25.9% |
| Operating Income | $22.9 million | $48.0 million | $30.9 million |
| Net Income | $15.2 million | $31.7 million | $21.9 million |
| Earnings Per Share (Diluted) | $0.56 | $1.18 | $0.81 |
| Cash from Operations | N/A | $68.9 million | $59.6 million |
| Cash & Equivalents (Ending) | $94.8 million | $94.8 million | $48.5 million |
| Total Debt | None reported | None reported | None reported |
Note: The company reported no long-term debt on the balance sheet. Outstanding letters of credit totaled $32.0 million.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 2.0% for the quarter and 1.9% year-to-date (YTD) compared to 2008. Comparable store sales grew 2.4% in the quarter and 2.0% YTD.
- Profitability Expansion: Net income surged 18.5% for the quarter and 44.9% YTD. Operating income increased 21.5% for the quarter and 55.2% YTD.
- Margin Improvement: Gross profit margin expanded to 27.0% from 26.2% (quarter) and 25.9% (YTD) in the prior year, driven by a 23.2% reduction in inventory shrink and lower fuel costs.
- Cost Dynamics: Diesel fuel costs decreased 52.0% for the quarter and 35.6% YTD. Conversely, self-insured health care benefits increased 19.4% for the quarter.
- Capital Expenditures: Purchases of property and equipment dropped significantly to $18.6 million YTD (1.5% of sales) from $36.4 million in the prior year (3.0% of sales).
Guidance, Outlook, and Risks
- Capital Plan: Management estimates a total investment of approximately $80.5 million for 2009, including plans to acquire the Binghamton-based Giant Markets. Funding is expected to come from internally generated cash flows.
- Dividends: The Board approved a quarterly dividend of $0.29 per share, payable August 17, 2009. Total dividends paid YTD were $0.58 per share.
- Market Risks:
- Competition: Competitors with greater financial resources may adversely affect the company's position.
- Pharmacy: Prescription growth is offset by generic penetration and mail-order shifts, though new pricing strategies have reversed previous downward trends.
- Commodity Prices: Dairy sales declined 3.8% due to product deflation; management anticipates a 4.0% decline for the full year. Fluctuating fuel prices remain a risk to delivered costs.
- Health Care Costs: Management expects health care benefit costs to increase approximately 8.0% for the year.
Investor Verification Checklist
- Acquisition Status: Verify the progress and regulatory approval status of the planned acquisition of Giant Markets in Binghamton.
- Health Care Costs: Monitor the trajectory of self-insured health care expenses, which rose 19.4% in Q2, against the projected 8.0% annual increase.
- Capital Allocation: Confirm the company's ability to fund the $80.5 million capital expansion plan solely through operating cash flows without incurring debt.
- Comparable Sales Quality: Assess the sustainability of the 2.4% comparable store sales growth in a deflationary environment where dairy prices are falling.
- Inventory Management: Validate the 23.2% improvement in inventory shrink rates as a recurring operational efficiency.